Danaher to Buy Masimo for $180/Share in a $9.9B Acquisition

1 min read
Source: Business Wire
TL;DR

Danaher will acquire Masimo for $180 per share in cash, valuing the deal at about $9.9 billion. The boards have approved the transaction, Masimo will become a standalone business unit and brand within Danaher’s Diagnostics segment, and the deal is expected to close in the second half of 2026 subject to regulatory approvals and other customary closing conditions.

Share this article

Want the full story? Read the original reporting

Read on Business Wire